MRI study of subconjunctival and intravitreal injections.

about

Intravitreal drug delivery in retinal disease: are we out of our depth?Transscleral passive and iontophoretic transport: theory and analysis.

P2860

Q38220453-ACD024AE-A9AC-44E1-B526-3585E3C44786 Q45305545-FA82063F-7D95-42C0-B4FF-A66D973133CD

P2860

MRI study of subconjunctival and intravitreal injections.

Item

http://www.wikidata.org/entity/Q36212580

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

MRI study of subconjunctival and intravitreal injections.

@ast

MRI study of subconjunctival and intravitreal injections.

@en

type

Item

label

MRI study of subconjunctival and intravitreal injections.

@ast

MRI study of subconjunctival and intravitreal injections.

@en

prefLabel

MRI study of subconjunctival and intravitreal injections.

@ast

MRI study of subconjunctival and intravitreal injections.

@en

P1476

MRI study of subconjunctival and intravitreal injections

@en

P2093

Hongshan Liu

http://www.w3.org/2001/XMLSchema#string

Jing-huei Lee

http://www.w3.org/2001/XMLSchema#string

Jinsong Hao

http://www.w3.org/2001/XMLSchema#string

P2860

The incidence of systemic side-effects following subconjunctival Mydricaine no. 1 injection

Novel drug delivery systems for retinal diseases. A review.

High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Systemic absorption of Soframycin after subconjunctival injection

Influence of permeant lipophilicity on permeation across human sclera

Review: practical issues in intravitreal drug delivery.

Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models

Challenges and obstacles of ocular pharmacokinetics and drug delivery.

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

MRI in ocular drug delivery.

P304

2353-2363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JPS.23127

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

S. Kevin Li

P577

2012-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223986004

http://www.w3.org/2001/XMLSchema#string

P698

22473517

http://www.w3.org/2001/XMLSchema#string

P932

3435115

http://www.w3.org/2001/XMLSchema#string

MRI study of subconjunctival and intravitreal injections.

about

P2860

P2860

MRI study of subconjunctival and intravitreal injections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932